发明名称 |
Anti-human respiratory syncytial virus (RSV) antibodies and methods of use |
摘要 |
Provided herein are antibodies or antigen-binding fragments thereof that immunospecifically bind to the fusion (F) protein of Respiratory Syncytial Virus (RSV). Also provided are methods for of prevention, treatment and diagnosis of viral infection and/or the treatment of one more symptoms of RSV-mediated disease. Methods of generating antibodies that immunospecifically bind RSV F protein also are provided. |
申请公布号 |
US9139642(B2) |
申请公布日期 |
2015.09.22 |
申请号 |
US201113809397 |
申请日期 |
2011.07.08 |
申请人 |
Crucell Holland B.V. |
发明人 |
Williamson Robert Anthony;Wadia Jehangir;Pascual Gabriel;Keogh Elissa |
分类号 |
A61K39/12;A61K39/155;C12N7/00;C07K16/10;A61K31/7056;A61K39/42;C07K16/46;G01N33/569;A61K39/00 |
主分类号 |
A61K39/12 |
代理机构 |
TraskBritt, P.C. |
代理人 |
TraskBritt, P.C. |
主权项 |
1. A humanized monoclonal anti-Respiratory Syncytial Virus (RSV) antibody or antigen-binding fragment thereof, wherein the humanized monoclonal anti-RSV antibody or antigen binding fragment thereof comprises:
a variable heavy (VH) chain containing the complementary determining region 1 (CDR1) of SEQ ID NO:405 or SEQ ID NO:437, the complementary determining region 2 (CDR2) of SEQ ID NO:406, and the complementary determining region 3 (CDR3) of SEQ ID NO:407; and a variable light (VL) chain containing the CDR1 of SEQ ID NO: 408, the CDR2 of SEQ ID NO: 409, and the CDR3 of SEQ ID NO:410. |
地址 |
Leiden NL |